Allergy Shots for Pollen: What They Are, How They Work, What to Expect
Allergy shots for pollen are subcutaneous immunotherapy (SCIT) targeting the tree, grass, and weed pollens identified by IgE testing as driving a patient's allergic rhinitis. The Cochrane meta-analysis (Calderón 2007, 51 RCTs, 2,871 patients) found symptom SMD −0.73 versus placebo. The regimen spans 3–5 years (approximately 60–80 injections). FDA-approved SLIT tablets exist for grass and ragweed monosensitization as a non-injection alternative.
8 peer-reviewed sources
Allergy shots for pollen are SCIT formulated against specific tree, grass, and weed pollens confirmed by IgE testing. Cochrane 51 RCTs found symptom SMD −0.73. Treatments take 3–5 years; FDA-approved daily oral SLIT tablets exist for grass and ragweed alternatives.
The essentials
Allergy shots for pollen — or pollen SCIT — are the category of subcutaneous immunotherapy formulated against the tree, grass, and weed pollens that drive a patient's spring, summer, and fall allergic rhinitis. This page is a top-of-funnel introduction for patients beginning their research: it assumes you don't yet know whether SCIT is a single visit or a multi-year program, whether it works for tree pollen as well as grass, or whether there's a non-injection alternative. Here is the 60-second foundation.
What pollen allergy shots are: SCIT that delivers escalating doses of specific pollen allergen extracts under the skin, retraining the immune system from IgE-dominated Th2 allergic responses toward regulatory T-cell (Treg) mediated tolerance. Per Cox 2011 PP3, the immune shift involves a 10- to 100-fold rise in allergen-specific IgG4 blocking antibodies, Treg expansion, and progressive decline in tissue mast cell and eosinophil reactivity — changes that persist for years after treatment ends.
Curex starts every patient with at-home IgE testing and allergist review to identify which specific pollens — tree, grass, ragweed — actually drive their symptoms before any immunotherapy decision is made. For eligible patients who choose SCIT, Curex's at-home allergy shot kit ($129/month) delivers the full course as one weekly home injection: personalized serum sterile-compounded to USP <797>, first dose Zoom-supervised by the prescribing allergist, prescribed epinephrine auto-injector confirmed on hand before day one.
What pollen allergy shots target: the allergens must be confirmed by IgE testing (skin prick test or serum-specific IgE blood panel) before the extract vial is formulated. The most common sensitizing pollens in the US: short ragweed (Ambrosia artemisiifolia, east of Rockies, late summer–fall), timothy grass and other grasses (late spring–summer), birch and oak trees (spring, Northeast), mountain cedar (Juniperus ashei, December–February, Texas/Oklahoma), and Bermuda grass (year-round, Southwest).
How well they work: the Cochrane meta-analysis by Calderón 2007 synthesized 51 RCTs across 2,871 patients and found a symptom standardized mean difference (SMD) of −0.73 (95% CI −0.97 to −0.50) and a medication-use SMD of −0.57 for seasonal allergic rhinitis. Per-allergen landmark data: grass SCIT achieves approximately 49% symptom reduction and 80% medication-score reduction (Walker 2001 JACI; P=.007). Ragweed SCIT significantly reduces season upper-airway symptoms and improves peak flow (Creticos 1996 NEJM). Birch SCIT achieves approximately 40% symptom and 50% medication reduction (Bødtger 2002 Allergy). Durham 1999 NEJM documented 3 additional years of remission after stopping a 3–4 year grass course.
The regimen: approximately 60–80 injections over 3–5 years. A conventional clinic-based protocol requires approximately 39 visits in Year 1 per Cox 2011 PP3 (weekly build-up plus early maintenance), each with a 30-minute post-injection observation window. With Curex, eligible patients complete the same weekly injection schedule at home — the first dose and every dose change Zoom-supervised by the prescribing allergist, thereafter self-administered with self-observation. Years 2–5 average 14 injections per year. The safety record is strong: 1 fatality per approximately 2.5 million injections long-run (Bernstein 2004 JACI). Adherence is the real-world ceiling: 23.9% of patients never return after the first injection (Tkacz 2021, n=103,207 MarketScan).
FDA-approved non-injection alternatives for specific pollens: Grastek (timothy grass, ALK, ages 5–65), Oralair (5-grass, Stallergenes, ages 5–65), and Ragwitek (short ragweed, Merck, ages 5–65 after 2021 expansion) are daily sublingual tablets dissolved under the tongue — not injections. They cover only specific allergens; polysensitized patients typically require SCIT. The clinical visit burden is substantially lower (one supervised first dose, then daily home dosing), but daily compliance for 3–5 years replaces the weekly clinic schedule.
How allergy shots retrain your immune system
Pollen allergy shots reprogram IgE-mediated allergic reactions by introducing escalating allergen doses that shift immunity toward tolerance. This mechanism is shared with SLIT tablets and SLIT drops — the delivery route differs, not the immune biology.
IgE Testing: Identify the Pollen Drivers
Skin prick testing or a serum-specific IgE blood panel identifies which tree, grass, and weed pollens trigger an immune response. Only confirmed sensitizers — positive IgE plus matching symptom calendar — belong in the extract vial.
Build-Up: Weekly Dose Escalation
26–28 weekly injections of escalating extract concentration build from 1:10,000 of maintenance concentration up to near-therapeutic levels. Each injection is followed by a 30-minute observation period — on your first dose and every dose change, your Curex allergist supervises live over Zoom; on routine maintenance doses, you self-observe at home with your prescribed epinephrine auto-injector on hand. Cluster schedules compress build-up to 7–13 visits.
Maintenance: Immune Reprogramming
At effective maintenance dose (approximately 7 µg Phl p 5 for timothy grass; 7–20 µg Amb a 1 for ragweed), injections every 2–4 weeks for 3–5 years. Allergen-specific IgG4 rises 10- to 100-fold; Th2-driven inflammation declines progressively.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Efficacy by allergen — what the data shows
Top-funnel orientation to the pollen SCIT evidence base — enough to evaluate whether the 3–5 year investment is justified for your situation.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
Do allergy shots work for all types of pollen?
SCIT can be formulated for most tree, grass, and weed pollens using standardized (FDA-listed) or non-standardized extracts. The strongest evidence is for standardized allergens: short ragweed (Amb a 1), grass mixes (timothy, orchard, Kentucky bluegrass), and birch (Bet v 1 family). Mountain cedar (Juniperus ashei) SCIT is practiced clinically but has a thin conventional RCT base — Thompson 2020 (Ann Allergy Asthma Immunol 2020;125:311-318) is proof-of-concept intralymphatic data only. For non-birch tree pollens (oak, hickory, maple), RCT evidence is largely extrapolated from birch via PR-10 cross-reactivity. Pollen SCIT cannot be extrapolated to food allergy — SCIT is not indicated for food allergens.
How long does it take to see results from pollen allergy shots?
Most patients notice meaningful symptom improvement during the first full pollen season after reaching maintenance dose — typically month 6–8 of a conventional build-up schedule. Patients who start build-up in October may first notice results the following spring. The full disease-modifying effect builds progressively over 2–3 years of maintenance. Clinical trials typically show the strongest results in patients at the 3-year mark, which is why Cox 2011 PP3 and EAACI guidelines both recommend a minimum of 3 years. Judging results after one or two build-up injections is premature — maintenance dose has not been reached.
What are the most common side effects of pollen allergy shots?
Local reactions at the injection site — redness, itching, and swelling — are the most common side effect, occurring in approximately 78–82% of SCIT patients at some point during treatment and approximately 16% of individual injections (Calabria/Tankersley LOCAL study, JACI 2009). Large local reactions (greater than 25mm, persisting over 24 hours) occur at approximately 0.4% of injections. Systemic reactions — sneezing, urticaria, mild asthma — occur at approximately 0.1% of injections and in 1.9% of patients (Epstein 2014). Fatal anaphylaxis: approximately 1 per 23.3 million injection visits, 2008–2012. Approximately 70% of systemic reactions occur within 30 minutes of injection — which is why Curex requires a prescribed epinephrine auto-injector confirmed on hand before your first dose, and supervises your first injection and every dose change live over Zoom. For routine maintenance doses at home, observe yourself for 30 minutes after each injection.
Are there pollen allergy shots for children?
Yes — SCIT is appropriate for children as young as 5 years per Cox 2011 PP3. The pediatric evidence is particularly strong: the PAT study (Möller 2002 JACI, Jacobsen 2007 Allergy) showed that children completing pollen SCIT had an adjusted OR of 4.6 for remaining asthma-free at 10-year follow-up versus untreated controls — the strongest disease-prevention effect in the immunotherapy literature. FDA-approved SLIT tablets (Grastek, Oralair, Ragwitek) are also approved for ages 5–65 as non-injection alternatives. The 30-minute observation period applies to children identically to adults.
Can pollen allergy shots be done at home?
Historically, SCIT was administered exclusively in-clinic with epinephrine available and a post-injection observation period — Cox 2011 PP3 reflected this as the standard of care. UnitedHealthcare ended coverage of home/self-administered SCIT effective January 1, 2023 for its commercial members, so insurance coverage varies. The Curex at-home allergy shot program ($129/month) is designed for eligible patients: the personalized serum is sterile-compounded to USP <797>, a prescribed epinephrine auto-injector must be confirmed on hand before the first dose, and your prescribing allergist supervises your first injection and every dose change live over Zoom. Allergist-confirmed candidacy — factoring in your sensitization profile, asthma history, and prior reaction history — determines whether at-home SCIT is appropriate for you. FDA-approved SLIT tablets (Grastek, Oralair, Ragwitek) remain an alternative for specific pollen allergens: taken daily at home after one supervised first dose.
What happens to pollen allergy symptoms after stopping shots?
Durham SR et al. (N Engl J Med 1999;341:468-475) documented sustained clinical benefit for at least 3 years after stopping a 3–4 year grass SCIT course, with persistent allergen-specific IgG4. Real-world disease-modification benefit is estimated at 3–12 years post-treatment for patients who complete the full course. Patients who stop SCIT prematurely — before reaching maintenance or before completing 3 years — are less likely to achieve durable remission. If symptoms return after successful SCIT, a second course can be considered; some allergists recommend maintenance continuation for patients who had severe disease before starting.
Related Articles
Allergy Shot Name: SCIT Defined & Explained | Curex
The clinical name for an allergy shot is subcutaneous immunotherapy (SCIT). There is no single brand name — each vial is custom-compounded. SLIT tablets have brand names; SCIT does not.
Read moreRagweed Allergy Shots: Evidence & Options | Curex Guide
Ragweed SCIT: strongest US single-allergen RCT (Creticos 1996 NEJM). Ragwitek FDA-approved ages 5–65. Season extended to 10–12 wks. At-home shots: $129/mo.
Read moreWhere To Get Allergy Shots | Curex Allergy Shot Guide
Get allergy shots at an allergist office or at home with Curex SCIT ($129/mo). HOPD sites can bill $24,400 for what a freestanding clinic charges $1,827.
Read moreAllergy Shot for Pollen: Mono vs Poly Guide | Curex
An allergy shot for pollen targets your specific IgE-sensitized pollen. True monosensitization is rarer than expected — most patients react to 3+ pollens. Guide inside.
Read moreAllergy Shots vs Drops: Evidence-Based Comparison | Curex
Allergy shots (SCIT) vs sublingual drops (SLIT): comparable efficacy per Nelson 2015, but SLIT has zero fatalities vs 1 per 2.5M shots. Full comparison.
Read morePollen Allergy Shots: Efficacy & Evidence | Curex Guide
Pollen SCIT has the strongest immunotherapy RCT base: grass 49% symptom reduction (Walker 2001), ragweed NEJM 1996, birch 40% (Bødtger 2002). Full regional map inside.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.